Could we replicate the vaccine breakthrough to tackle the even greater threat of climate change? This analysis looks at how and where the winning vaccine formula might be deployed in the race to stop our planet overheating.
When pharmaceutical companies began distributing COVID-19 vaccines in late 2020 and early 2021, the European Union fell immediately behind the United Kingdom and United States in the number of doses administered. It faced shortages while, at the same time, allowing a substantial share of the vaccines it was receiving to be exported. This slow initial roll-out – which happened just as another wave of the pandemic was hitting many EU member states – has been extremely costly in human and economic terms and has battered the reputation of the European Commission.